SEC Filing Summary for Apyx Medical Corp

On June 15, 2026, Shawn David Roman, Chief Operating Officer of Apyx Medical Corp, engaged in several transactions involving the company's Common Stock. He exercised 15,000 stock options with an exercise price of $3.23 per share. As part of this transaction, 10,533 shares were withheld by the issuer to cover the exercise price, resulting in a net issuance of 4,467 shares to Mr. Roman. These shares are held indirectly by The Roman Family Revocable Trust. Additionally, Mr. Roman acquired 15,000 shares of Common Stock at $3.23 per share and disposed of 10,533 shares at $4.60 per share, with the shares held by the trust. Following these transactions, the trust holds 16,467 shares of Common Stock. The stock options exercised have an expiration date of May 1, 2027.